Seeing your biggest competitor fail is the next best thing to achieving success yourself. That’s the story of Elevance Health ...

A total of 8 analyst ratings have been received for Elevance Health, with the consensus rating being Outperform. The average ...

We recently published a list of Top 20 Falling Stocks with Unusual Volume. In this article, we are going to take a look at ...

In a report released yesterday, David Toung from Argus Research maintained a Buy rating on Elevance Health (ELV – Research Report). The ...

Elevance Health saw net income fall 2.9% to $2.2 billion during the first quarter, the insurer announced Tuesday.

Elevance (ELV) stock thrives with fee-based plans, preventive care, and disciplined capital management, ensuring growth and strong investor returns. See more.

We recently published a list of 10 Best Telehealth Stocks to Buy Now. In this article, we are going to take a look at where ...

They currently have a $478.00 price target on the stock. Several other research analysts have also recently weighed in on the company. Stephens cut Elevance Health from an “overweight” rating ...

Elevance Health posts strong Q1 with premium, Medicare, and CarelonRx growth, reaffirming 2025 EPS guidance above Wall Street ...

This compares to the stock's 8% gain over the past four weeks. Elevance Health’s share price benefited from investors seeking stability amid heightened market volatility. A sharp sell-off in ...

Argus raised shares of Elevance Health from a “hold” rating to a “buy” rating and set a $450.00 target price on the stock in a report on Monday, March 17th. Barclays increased their price ...